NCT01404689View on ClinicalTrials.gov

Study to Determine if the Midazolam-Meperidine-Dexmedetomidine is Superior to the Midazolam-Meperidine for Sedation During ERCP

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Undergoing ERCP for Diagnostic or Therapeutic Purposes
Interventions
DRUG

Dexmedetomidine

dexmedetomidine 1μg/Kg•hr IV continuous infusion, initiated 15 min before the procedure (ERCP) till complete procedure

OTHER

normal saline

0.9% NaCl 1μg/Kg•hr IV continuous infusion, initiated 15 min before the procedure (ERCP) till complete procedure

Trial Locations (1)

463-707

Division of Gastroenterology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
collaborator

Hana Pharm Co., Ltd.

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT01404689 - Study to Determine if the Midazolam-Meperidine-Dexmedetomidine is Superior to the Midazolam-Meperidine for Sedation During ERCP | Biotech Hunter | Biotech Hunter